Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety

Published:2024-02 Issue: Volume:265 Page:116048
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yang Wenjiao,Gong Xudong,Sun Haiguo,Wu Chunhui,Suo Jin,Ji Jing,Jiang Xiangrui,Shen Jingshan^ORCID,He Yang,Aisa Haji Akber

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference75 articles.

1. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD);Peng;Basic Clin. Pharmacol. Toxicol.,2022

2. The endocannabinoid system as an emerging target of pharmacotherapy;Pacher;Pharmacol. Rev.,2006

3. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications;Lambert;J. Med. Chem.,2005

4. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications;Bilbao;BMC Med.,2022

5. Understanding the modulatory effects of cannabidiol on alzheimer's disease;Xiong;Brain Sci.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Characterization of Novel Cannabidiol-Based Derivatives with Potent Antioxidant Activities;International Journal of Molecular Sciences;2024-09-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP